Janux Therapeutics, Inc. (JANX): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001193125-26-449918

Filer

Janux Therapeutics, Inc. (CIK 1817713)